Pharmacovigilance: The type of activity aimed at the identification, assessment, understanding and prevention of adverse events
to use of a medicinal product.
The order activity for pharmacovigilance is established to the Republic of Belarus by the Technical Code of Good Practice 564-2015 (33050) «Good Pharmacovigilance Practice».
Fortiva Med LLC`s pharmacovigilance system was established for to carry out activities aimed at medicinal products safety monitoring and early identification of any changes in Risk-benefit balance of our medicinal products, as well as the development and implementation of measures to ensure the use medicinal products in excess of the benefit over the risk.
Qualified Person for Pharmacovigilance of Fortiva Med LLC:
Mobile phone (available 24/7): +375 44 77 962 77.
Email address: firstname.lastname@example.org
If you have information about an adverse reaction or lack of therapeutic efficacy of Fortiva Med LLC`s medicines products, fill out the form “Notification of a suspected adverse reaction to a medicinal product” on this page. Please, read the terms and definitions of the Technical Code of Good Practice 564-2015 (33050) before completing the form.
See the link below:
Qualified Person for Pharmacovigilance of Fortiva Med LLC will contact you after receiving your message.
We guarantee the confidentiality of personal data provided by you and documents, except for cases stipulated by the requirements of the national legislation.